Teva Pharmaceutical beats estimates as acquisition lifts revenue – CNBC


CNBC
Teva Pharmaceutical beats estimates as acquisition lifts revenue
CNBC
Teva Pharmaceutical Industries reported better than expected third-quarter profit as sales were boosted by its $40.5 billion acquisition of Allergan’s generic drug business on Aug. 2. Israel-based Teva said on Tuesday it earned $1.31 per share
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Falls Despite Q3 Earnings BeatInvestorplace.com
Teva Pharmaceutical Industries Ltd.’s Q3 Helped by Actavis Generics Deal — but Not Quite EnoughMotley Fool
Teva Pharmaceutical Industries (TEVA) Erez Vigodman on Q3 2016 Results – Earnings Call TranscriptSeeking Alpha
The Cerbat Gem -24/7 Wall St. -Chester News
all 74 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd